More S.African pregnant women contracting HIV, study reports

December 10, 2012

A new study on Monday showed increased HIV infection rates among pregnant women living in areas with high migrant labour in South Africa, the country with one of the world's highest caseloads.

Infections in the eastern province of Mpumalanga jumped from 34.7 percent in 2009 to 36.7 percent.

Aaron Motsoaledi said some of the districts in these areas had rates above the national antenatal rate of 29.5 percent.

"In areas where we see new mining operations, news towns, constructions and new people coming in, we expect something like this higher prevalence rate to happen," said Motsoaledi.

"It needs our attention," he added.

The farming and mining provinces of Free State, North West, Limpopo also recorded increases.

The study was conducted in 2011 on some 33,446 women who attended antenatal clinics for the first time.

The semi-arid Namaqua district in the sparsely inhabited region of Northern Cape recorded the lowest prevalence rate at 6.2 percent. However, the country's , Gauteng province, which includes Johannesburg and the capital Pretoria showed a slight decrease from 30.4 percent in 2010 to 28.7 percent in 2011.

In South Africa six million people currently live with the virus that causes AIDS.

After years of refusing to roll out drugs, the country now runs the world's largest treatment programme, serving 1.3 million people.

plan to step up awareness campaigns to fight the scourge.

Explore further: South Africa reports new success in saving newborns from HIV

Related Stories

South Africa reports new success in saving newborns from HIV

July 19, 2012
About 117,000 babies were saved from HIV infection last year under South Africa's scheme to prevent mothers from passing on the disease during childbirth, health official said Thursday.

S.Africa seals record deal for low-cost ARVs: minister

November 29, 2012
South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.